Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 08, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of insider share transactions and contains no financial performance data.
Material Changes
The only material change disclosed is a specific transaction involving a director:
- Mr. A P Witty: Transferred 415 Ordinary shares by gift on December 07, 2006.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share transfer in accordance with Disclosure Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Director A P Witty gifted 415 shares on December 07, 2006.
- The company was advised of this transaction on the same date.
- No financial results or strategic updates are included in this specific filing.